Skip to content
WorldBrand.AI

Emergen-C controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2013

    Class action over health-benefit marketing claims

    A California class action alleged that Alacer marketed Emergen-C as reducing the risk of or preventing colds and flu without adequate scientific support. A judge preliminarily approved a $6.45 million settlement in December 2013; final approval followed in June 2014. The settlement provided a refund process for eligible consumers and was not described here as an admission of liability.

    Source